Concepts (199)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Nasal Mucosa | 4 | 2025 | 416 | 1.100 |
Why?
|
| Orthomyxoviridae Infections | 1 | 2024 | 255 | 0.770 |
Why?
|
| Immunologic Memory | 4 | 2024 | 1377 | 0.650 |
Why?
|
| Immunity | 2 | 2024 | 1003 | 0.510 |
Why?
|
| Single-Cell Analysis | 7 | 2025 | 2540 | 0.500 |
Why?
|
| Biological Evolution | 1 | 2020 | 1076 | 0.470 |
Why?
|
| Immunity, Cellular | 1 | 2020 | 1561 | 0.450 |
Why?
|
| Cell Communication | 2 | 2020 | 1660 | 0.430 |
Why?
|
| HIV | 1 | 2020 | 1597 | 0.430 |
Why?
|
| HIV Infections | 11 | 2022 | 17569 | 0.430 |
Why?
|
| Host-Pathogen Interactions | 1 | 2020 | 1469 | 0.390 |
Why?
|
| Influenza A virus | 2 | 2024 | 460 | 0.310 |
Why?
|
| Interferon Type I | 2 | 2024 | 569 | 0.300 |
Why?
|
| Simian Acquired Immunodeficiency Syndrome | 2 | 2024 | 545 | 0.300 |
Why?
|
| Simian immunodeficiency virus | 2 | 2024 | 814 | 0.280 |
Why?
|
| Lymphocytes | 3 | 2020 | 2614 | 0.270 |
Why?
|
| Respiratory Mucosa | 2 | 2021 | 439 | 0.270 |
Why?
|
| Immunity, Innate | 4 | 2020 | 3080 | 0.230 |
Why?
|
| Lentivirus Infections | 1 | 2024 | 12 | 0.230 |
Why?
|
| HIV-1 | 5 | 2020 | 6961 | 0.220 |
Why?
|
| Sequence Analysis, RNA | 4 | 2020 | 2040 | 0.220 |
Why?
|
| Epithelial Cells | 3 | 2024 | 3703 | 0.210 |
Why?
|
| CD8-Positive T-Lymphocytes | 5 | 2022 | 4648 | 0.210 |
Why?
|
| Acute Disease | 4 | 2020 | 7243 | 0.200 |
Why?
|
| Influenza, Human | 3 | 2024 | 1541 | 0.200 |
Why?
|
| Viral Load | 3 | 2020 | 3396 | 0.200 |
Why?
|
| Glucocorticoid-Induced TNFR-Related Protein | 1 | 2021 | 40 | 0.190 |
Why?
|
| Interleukin-17 | 2 | 2024 | 924 | 0.170 |
Why?
|
| Acute-Phase Reaction | 1 | 2020 | 91 | 0.170 |
Why?
|
| Minor Histocompatibility Antigens | 1 | 2021 | 303 | 0.170 |
Why?
|
| Immunoglobulin Variable Region | 1 | 2020 | 420 | 0.160 |
Why?
|
| Lymphoid Tissue | 1 | 2020 | 445 | 0.160 |
Why?
|
| Enterocytes | 1 | 2020 | 220 | 0.160 |
Why?
|
| Peptidyl-Dipeptidase A | 1 | 2020 | 325 | 0.150 |
Why?
|
| Systems Integration | 1 | 2020 | 430 | 0.150 |
Why?
|
| Embryonic Development | 1 | 2022 | 724 | 0.140 |
Why?
|
| Goblet Cells | 1 | 2020 | 300 | 0.140 |
Why?
|
| Fetal Development | 1 | 2022 | 779 | 0.140 |
Why?
|
| Macrophages, Alveolar | 1 | 2019 | 415 | 0.140 |
Why?
|
| Colloids | 2 | 2013 | 125 | 0.130 |
Why?
|
| Receptors, Antigen, B-Cell | 1 | 2019 | 547 | 0.130 |
Why?
|
| T-Lymphocytes, Cytotoxic | 2 | 2021 | 1801 | 0.130 |
Why?
|
| Daunorubicin | 2 | 2013 | 157 | 0.130 |
Why?
|
| T-Lymphocytes, Regulatory | 2 | 2021 | 3114 | 0.130 |
Why?
|
| Gene Expression Profiling | 3 | 2021 | 9538 | 0.130 |
Why?
|
| Germinal Center | 1 | 2018 | 380 | 0.130 |
Why?
|
| Adaptive Immunity | 1 | 2020 | 733 | 0.130 |
Why?
|
| DNA Barcoding, Taxonomic | 1 | 2016 | 134 | 0.120 |
Why?
|
| DNA | 3 | 2013 | 7214 | 0.120 |
Why?
|
| Histocompatibility Antigens Class I | 1 | 2021 | 1361 | 0.120 |
Why?
|
| CD4 Lymphocyte Count | 1 | 2020 | 2596 | 0.120 |
Why?
|
| Killer Cells, Natural | 2 | 2020 | 2211 | 0.110 |
Why?
|
| Anti-Retroviral Agents | 2 | 2020 | 1789 | 0.110 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2020 | 1854 | 0.110 |
Why?
|
| Receptors, Antigen, T-Cell, alpha-beta | 1 | 2016 | 812 | 0.100 |
Why?
|
| Lipopolysaccharides | 1 | 2020 | 2219 | 0.100 |
Why?
|
| Tuberculosis, Pulmonary | 1 | 2019 | 843 | 0.100 |
Why?
|
| Deoxyribonuclease EcoRI | 1 | 2011 | 30 | 0.100 |
Why?
|
| Histocompatibility Antigens Class II | 1 | 2016 | 1441 | 0.100 |
Why?
|
| Antiretroviral Therapy, Highly Active | 1 | 2020 | 1903 | 0.100 |
Why?
|
| Influenza Vaccines | 1 | 2019 | 781 | 0.100 |
Why?
|
| Inflammation Mediators | 1 | 2020 | 1892 | 0.100 |
Why?
|
| Biophysics | 1 | 2013 | 379 | 0.100 |
Why?
|
| Mycobacterium tuberculosis | 2 | 2020 | 1930 | 0.090 |
Why?
|
| Interferon-gamma | 2 | 2019 | 3160 | 0.090 |
Why?
|
| Gene Regulatory Networks | 1 | 2020 | 1752 | 0.090 |
Why?
|
| Palatine Tonsil | 2 | 2022 | 193 | 0.090 |
Why?
|
| Receptors, CXCR5 | 2 | 2022 | 88 | 0.090 |
Why?
|
| CD4-Positive T-Lymphocytes | 2 | 2020 | 4415 | 0.090 |
Why?
|
| Disease Management | 1 | 2020 | 2536 | 0.080 |
Why?
|
| Spectrum Analysis | 1 | 2011 | 449 | 0.080 |
Why?
|
| Immunity, Mucosal | 2 | 2025 | 498 | 0.080 |
Why?
|
| Microfluidic Analytical Techniques | 1 | 2016 | 820 | 0.080 |
Why?
|
| Hypersensitivity | 1 | 2018 | 1172 | 0.080 |
Why?
|
| RNA | 2 | 2016 | 2720 | 0.080 |
Why?
|
| Animals | 9 | 2024 | 169246 | 0.080 |
Why?
|
| Drug Resistance, Neoplasm | 2 | 2021 | 5341 | 0.080 |
Why?
|
| Antibodies, Viral | 1 | 2019 | 3216 | 0.070 |
Why?
|
| Lung | 3 | 2021 | 10099 | 0.070 |
Why?
|
| Mice | 7 | 2024 | 82029 | 0.070 |
Why?
|
| Antiviral Agents | 2 | 2016 | 3073 | 0.070 |
Why?
|
| Intestines | 1 | 2016 | 1909 | 0.070 |
Why?
|
| Dendritic Cells | 1 | 2018 | 2747 | 0.070 |
Why?
|
| Nanoparticles | 2 | 2019 | 1985 | 0.070 |
Why?
|
| Humans | 23 | 2025 | 768166 | 0.070 |
Why?
|
| B-Lymphocytes | 1 | 2019 | 4793 | 0.060 |
Why?
|
| Glioblastoma | 1 | 2021 | 3464 | 0.060 |
Why?
|
| Mice, Inbred C57BL | 1 | 2024 | 22379 | 0.060 |
Why?
|
| Cytokines | 1 | 2020 | 7453 | 0.060 |
Why?
|
| Stem Cells | 1 | 2018 | 3537 | 0.060 |
Why?
|
| T-Lymphocytes | 2 | 2019 | 10266 | 0.060 |
Why?
|
| Longitudinal Studies | 1 | 2020 | 14783 | 0.050 |
Why?
|
| Young Adult | 5 | 2021 | 60066 | 0.050 |
Why?
|
| Tumor Microenvironment | 1 | 2016 | 3948 | 0.050 |
Why?
|
| Female | 9 | 2025 | 397192 | 0.050 |
Why?
|
| Candidiasis | 1 | 2024 | 367 | 0.050 |
Why?
|
| Adolescent | 5 | 2020 | 89169 | 0.050 |
Why?
|
| Nasopharynx | 1 | 2024 | 420 | 0.050 |
Why?
|
| Mycoses | 1 | 2024 | 386 | 0.050 |
Why?
|
| Transcription, Genetic | 3 | 2020 | 7608 | 0.040 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2021 | 11878 | 0.040 |
Why?
|
| Feedback | 1 | 2024 | 799 | 0.040 |
Why?
|
| Interferons | 1 | 2024 | 720 | 0.040 |
Why?
|
| Interleukin-7 Receptor alpha Subunit | 1 | 2019 | 50 | 0.040 |
Why?
|
| Adult | 7 | 2025 | 223646 | 0.040 |
Why?
|
| Lymphocyte Subsets | 1 | 2020 | 313 | 0.040 |
Why?
|
| Aging | 1 | 2018 | 8744 | 0.040 |
Why?
|
| Chemokine CXCL13 | 1 | 2019 | 62 | 0.040 |
Why?
|
| Complementarity Determining Regions | 1 | 2019 | 154 | 0.040 |
Why?
|
| Antibody Affinity | 1 | 2019 | 252 | 0.040 |
Why?
|
| Lymphocyte Depletion | 1 | 2020 | 605 | 0.040 |
Why?
|
| Cells, Cultured | 3 | 2020 | 19015 | 0.040 |
Why?
|
| Hemagglutinin Glycoproteins, Influenza Virus | 1 | 2019 | 163 | 0.040 |
Why?
|
| Interleukin-4 Receptor alpha Subunit | 1 | 2018 | 57 | 0.040 |
Why?
|
| Latent Tuberculosis | 1 | 2021 | 224 | 0.040 |
Why?
|
| Cell Cycle | 2 | 2016 | 2932 | 0.040 |
Why?
|
| Mucous Membrane | 1 | 2021 | 659 | 0.040 |
Why?
|
| Lymphocyte Activation | 2 | 2020 | 5505 | 0.040 |
Why?
|
| Mice, Transgenic | 2 | 2020 | 9561 | 0.040 |
Why?
|
| Melanoma | 1 | 2016 | 5706 | 0.040 |
Why?
|
| Granuloma | 1 | 2019 | 329 | 0.030 |
Why?
|
| Immunization, Secondary | 1 | 2019 | 373 | 0.030 |
Why?
|
| Immunoglobulin Heavy Chains | 1 | 2019 | 648 | 0.030 |
Why?
|
| Receptors, Virus | 1 | 2020 | 652 | 0.030 |
Why?
|
| Skin Neoplasms | 1 | 2016 | 5863 | 0.030 |
Why?
|
| RNA, Viral | 1 | 2025 | 2872 | 0.030 |
Why?
|
| Treatment Outcome | 2 | 2020 | 65371 | 0.030 |
Why?
|
| Interleukin-13 | 1 | 2018 | 390 | 0.030 |
Why?
|
| Protein Engineering | 1 | 2019 | 553 | 0.030 |
Why?
|
| Hyperplasia | 1 | 2018 | 1151 | 0.030 |
Why?
|
| Immunity, Humoral | 1 | 2019 | 610 | 0.030 |
Why?
|
| Antigens, Viral | 1 | 2019 | 995 | 0.030 |
Why?
|
| Serine Endopeptidases | 1 | 2020 | 1027 | 0.030 |
Why?
|
| Fetus | 1 | 2022 | 1883 | 0.030 |
Why?
|
| Kinetics | 2 | 2013 | 6329 | 0.030 |
Why?
|
| Interleukin-4 | 1 | 2018 | 1156 | 0.030 |
Why?
|
| Interleukins | 1 | 2019 | 796 | 0.030 |
Why?
|
| Microphthalmia-Associated Transcription Factor | 1 | 2016 | 257 | 0.030 |
Why?
|
| Chronic Disease | 2 | 2020 | 9384 | 0.030 |
Why?
|
| Macaca mulatta | 1 | 2020 | 2363 | 0.030 |
Why?
|
| Nanofibers | 1 | 2013 | 68 | 0.030 |
Why?
|
| Transcriptional Activation | 1 | 2019 | 1750 | 0.030 |
Why?
|
| Base Sequence | 2 | 2016 | 12421 | 0.030 |
Why?
|
| Nasal Polyps | 1 | 2018 | 412 | 0.030 |
Why?
|
| Spectrophotometry | 1 | 2013 | 292 | 0.030 |
Why?
|
| Nanotubes | 1 | 2013 | 83 | 0.030 |
Why?
|
| Oscillometry | 1 | 2013 | 151 | 0.030 |
Why?
|
| Vaccination | 1 | 2025 | 3437 | 0.030 |
Why?
|
| Solutions | 1 | 2013 | 409 | 0.020 |
Why?
|
| Phenotype | 2 | 2021 | 16726 | 0.020 |
Why?
|
| Cell Line, Tumor | 2 | 2021 | 17140 | 0.020 |
Why?
|
| Thermodynamics | 1 | 2013 | 591 | 0.020 |
Why?
|
| Optics and Photonics | 1 | 2013 | 307 | 0.020 |
Why?
|
| HLA Antigens | 1 | 2016 | 1334 | 0.020 |
Why?
|
| Germ-Line Mutation | 1 | 2019 | 1885 | 0.020 |
Why?
|
| Up-Regulation | 1 | 2020 | 4146 | 0.020 |
Why?
|
| Genomics | 2 | 2018 | 5926 | 0.020 |
Why?
|
| Rhinitis | 1 | 2018 | 753 | 0.020 |
Why?
|
| Stromal Cells | 1 | 2016 | 1336 | 0.020 |
Why?
|
| Nucleic Acid Hybridization | 1 | 2011 | 1305 | 0.020 |
Why?
|
| Antineoplastic Agents | 1 | 2013 | 13676 | 0.020 |
Why?
|
| Sodium Chloride | 1 | 2011 | 584 | 0.020 |
Why?
|
| Nucleic Acid Conformation | 1 | 2013 | 899 | 0.020 |
Why?
|
| Male | 6 | 2025 | 364719 | 0.020 |
Why?
|
| Sinusitis | 1 | 2018 | 997 | 0.020 |
Why?
|
| Drug Therapy, Combination | 1 | 2019 | 6316 | 0.020 |
Why?
|
| Middle Aged | 4 | 2025 | 223492 | 0.020 |
Why?
|
| Child | 3 | 2020 | 80917 | 0.020 |
Why?
|
| Tuberculosis | 1 | 2020 | 2029 | 0.020 |
Why?
|
| Disease Progression | 1 | 2024 | 13671 | 0.020 |
Why?
|
| Cell Line | 1 | 2020 | 15597 | 0.020 |
Why?
|
| Ligands | 1 | 2013 | 3284 | 0.020 |
Why?
|
| Aged | 3 | 2025 | 171504 | 0.020 |
Why?
|
| Mice, Knockout | 1 | 2021 | 14488 | 0.020 |
Why?
|
| Neoplasm Metastasis | 1 | 2016 | 4912 | 0.020 |
Why?
|
| Epigenesis, Genetic | 1 | 2018 | 3833 | 0.010 |
Why?
|
| Cell Movement | 1 | 2016 | 5210 | 0.010 |
Why?
|
| Cell Proliferation | 1 | 2019 | 10474 | 0.010 |
Why?
|
| Endothelial Cells | 1 | 2016 | 3589 | 0.010 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 3115 | 0.010 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 3238 | 0.010 |
Why?
|
| Time Factors | 2 | 2016 | 40218 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2021 | 18349 | 0.010 |
Why?
|
| Age Factors | 1 | 2018 | 18412 | 0.010 |
Why?
|
| Cell Differentiation | 1 | 2019 | 11669 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2018 | 22291 | 0.010 |
Why?
|
| Pregnancy | 1 | 2022 | 30256 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 2020 | 26422 | 0.010 |
Why?
|
| Immunotherapy | 1 | 2016 | 4755 | 0.010 |
Why?
|
| Pandemics | 1 | 2020 | 8748 | 0.010 |
Why?
|
| Apoptosis | 1 | 2016 | 9523 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2018 | 20227 | 0.010 |
Why?
|
| Protein Binding | 1 | 2011 | 9343 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2011 | 17622 | 0.010 |
Why?
|
| Models, Statistical | 1 | 2013 | 5107 | 0.010 |
Why?
|
| Infant | 1 | 2020 | 36535 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 2016 | 11928 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2020 | 42669 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2016 | 41754 | 0.010 |
Why?
|
Concepts
(199)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(43)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_